Human‐specific polymorphic pseudogenization of SIGLEC12 protects against advanced cancer progression-Reference-Cited by-同舟云学术

Human‐specific polymorphic pseudogenization of SIGLEC12 protects against advanced cancer progression

Published:2020-12-08 Issue:2 Volume:3 Page:69-82
ISSN:2573-9832
Container-title:FASEB BioAdvances
language:en
Short-container-title:FASEB BioAdvances

Author:

Siddiqui Shoib S¹^ORCID,Vaill Michael¹^ORCID,Do Raymond¹^ORCID,Khan Naazneen¹^ORCID,Verhagen Andrea L¹^ORCID,Zhang Wu²^ORCID,Lenz Heinz‐Josef²^ORCID,Johnson‐Pais Teresa L³^ORCID,Leach Robin J³⁴^ORCID,Fraser Gary⁵^ORCID,Wang Charles⁵^ORCID,Feng Gen‐Sheng¹^ORCID,Varki Nissi¹^ORCID,Varki Ajit¹^ORCID

Affiliation:

1. Departments of Medicine, Cellular and Molecular Medicine, and Pathology, Glycobiology Research and Training Cente and Center for Academic Research and Training in Anthropogeny University of California San Diego CA USA

2. University of Southern California Norris Comprehensive Cancer Center Los Angeles CA USA

3. Department of Urology University of TX Health Science Center San Antonio TX USA

4. Departments of Cell Systems and Anatomy University of TX Health Science Center San Antonio TX USA

5. School of Public Health Loma Linda University Loma Linda CA USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fba.2020-00092

Reference62 articles.

1. Systemic Pathology of Chimpanzees

2. Comparative analysis of cancer genes in the human and chimpanzee genomes

3. On the apparent rarity of epithelial cancers in captive chimpanzees